Ratings DaVita Inc.

Equities

DVA

US23918K1088

Market Closed - Nyse Other stock markets 04:00:02 2024-04-23 pm EDT			5-day change	1st Jan Change
133.9 ^USD	+1.05%		+3.18%	+27.83%

Apr. 22	DaVita Inc. Announces Designing and Opening the First All-Electric Net-Zero Dialysis Center in the U.S, Powered by Solar Energy	CI
Apr. 10	Davita Announces Dennis Pullin to Its Board of Directors	CI

Summary

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
The company presents an interesting fundamental situation from a short-term investment perspective.
According to Refinitiv, the company's ESG score for its industry is good.

Strengths

Over the past year, analysts have regularly revised upwards their sales forecast for the company.
Sales forecast by analysts have been recently revised upwards.
For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
Over the past four months, analysts' average price target has been revised upwards significantly.
Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.

Weaknesses

According to forecast, a sluggish sales growth is expected for the next fiscal years.
The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
The company appears highly valued given the size of its balance sheet.
The average consensus view of analysts covering the stock has deteriorated over the past four months.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Healthcare Facilities & Services

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
DAVITA INC.	+27.83%	11.62B		B-
CVS HEALTH CORPORATION	-13.25%	87.77B		B-
HCA HEALTHCARE, INC.	+18.01%	82.08B		C+
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+11.97%	30.03B		C+
LABORATORY CORPORATION OF AMERICA HOLDINGS	-8.50%	17.08B		B
FRESENIUS SE & CO. KGAA	-1.46%	16.41B		A-
EUROFINS SCIENTIFIC SE	+4.44%	12.37B		A-
FRESENIUS MEDICAL CARE AG	+5.11%	12.17B		A-
PURE HEALTH HOLDING	-31.05%	11.89B	-	-
UNIVERSAL HEALTH SERVICES, INC.	+8.18%	10.85B		B-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes